Subclinical atherosclerosis in gouty arthritis patients: A comparative study

Rheumatology International

Volumn 32, Issue 6, 2012, Pages 1769-1773

  Çukurova, Selçuk ^a   Pamuk, Ömer Nuri ^a   Ünlü, Ercüment ^a   Pamuk, Gülsüm Emel ^a   Çakir, Necati ^a  

^a TRAKYA UNIVERSITY   (Turkey)

Author keywords

Asymptomatic hyperuricemia; Atherosclerosis; Gouty arthritis; Rheumatoid arthritis

Indexed keywords

ALLOPURINOL; ANTIGOUT AGENT; CHOLESTEROL; NONSTEROID ANTIINFLAMMATORY AGENT; STEROID; URIC ACID;

ADULT; AGING; ARTHRITIS; ARTICLE; ASYMPTOMATIC DISEASE; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; B SCAN; CAROTID ARTERY; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE DURATION; ECHOGRAPHY; FEMALE; GOUT; HUMAN; HYPERURICEMIA; INFLAMMATION; INTIMA; INTIMA MEDIA THICKNESS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK FACTOR; TUNICA MEDIA; URIC ACID BLOOD LEVEL;

ADULT; ARTHRITIS, GOUTY; ARTHRITIS, RHEUMATOID; ASYMPTOMATIC DISEASES; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; HYPERURICEMIA; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PLAQUE, ATHEROSCLEROTIC; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; TURKEY;

EID: 84863864023     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-011-1900-4     Document Type: Article

References (22)

1. Abbott RD, Brand FN, Kannel WB, Castelli WP (1988) Gout and coronary heart disease: the Framingham Study. J Clin Epidemiol 41:237-242
2. Baker JF, Krishnan E, Chen L, Schumacher HR (2005) Serum uric acid and cardiovascular disease: recent developments, and where do they leave us? Am J Med 118:816-826
3. Butler R, Morris AD, Belch JJ, Hill A, Struthers AD (2000) Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension. Hypertension 35:746-751
4. Choi HK, Curhan G (2007) Independent impact of gout on mortality and risk for coronary heart disease. Circulation 116:894-900
5. Culleton BF, Larson MG, Kannel WB, Levy D (1999) Serum uric acid and risk for cardiovascular disease and death: the Framingham heart study. Ann Intern Med 131:7-13
6. George J, Carr E, Davies J, Belch JJ, Struthers A (2006) Highdose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid. Circulation 114:2508-2516
7. Gibson T, Rodgers AV, Simmonds HA, Court-Brown F, Todd E, Meilton V (1983) A controlled study of diet in patients with gout. Ann Rheum Dis 42:123-127
8. Grundy SM, Brewer Jr HB, Cleeman JI et al. (2004) Definition of metabolic syndrome. Report of the national heart, lung, and blood institute/american heart association conference on scientific issues related to definition. Circulation 109:433-438
9. Iso H, Sato S, Kitamura A, Imano H, Kiyama M, Yamagishi K et al (2007) Metabolic syndrome and the risk of ischemic heart disease and stroke among Japanese men and women. Stroke 38:1744-1751
10. Janssens HJ, van de Lisdonk EH, Bor H, van den Hoogen HJ, Janssen M (2003) Gout, just a nasty event or a cardiovascular signal? A study from primary care. Fam Pract 20:413-416
11. Krishnan E, Baker JF, Furst DE, Schumacher HR (2006) Gout and the risk of acute myocardial infarction. Arthritis Rheum 54:2688-2696
12. Libby P (2008) Role of inflammation in atherosclerosis associated with rheumatoid arthritis. Am J Med 121(10 Suppl 1): S21-S31
13. Mazzali M, Kanellis J, Han L, Feng L, Xia YY, Chen Q, Kang DH, Gordon KL, Watanabe S, Nakagawa T, Lan HY, Johnson RJ (2002) Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Renal Physiol 282:F991-F997
14. Pascual E (1991) Persistence of monosodium urate crystals and lowgrade inflammation in the synovial fluid of patients with untreated gout. Arthritis Rheum 34:141-145
15. Puig JG, Martinez PA (2008) Hyperuricemia, gout and metabolic syndrome. Curr Opin Rheumatol 20:187-191
16. Ridker PM (1999) Inflammation, atherosclerosis, and cardiovascular risk: an epidemiologic view. Blood Coagul Fibrinolysis 10(Suppl 1):S9-S12
17. Salmon JE, Roman MJ (2008) Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus. Am J Med 121(10 Suppl 1):S3-S8
18. Tiong AY, Brieger D (2005) Inflammation and coronary artery disease. Am Heart J 150:11-18
19. Tousoulis D, Charakida M, Stefanadis C (2006) Endothelial function and inflammation in coronary artery disease. Heart 92:441-444
20. Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ, Yu TF (1977) Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 20:895-900
21. Ward MM (1999) Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus. Arthritis Rheum 42:338-346
22. Yokokawa H, Yasumura S, Tanno K, Ohsawa M, Onoda T, Itai K et al (2011) Serum low-density lipoprotein to high-density lipoprotein ratio as a predictor of future acute myocardial infarction among men in a 2.7-year cohort study of a Japanese northern rural population. J Atheroscler Thromb 18(2):89-98